Pfizer Said Close to $14 Billion Deal to Acquire Medivation

Pfizer Said Close to $14 Billion Deal to Acquire Medivation


Pfizer Inc. is close to an agreement to buy Medivation Inc. for about $14 billion, people familiar with the situation said, the latest in a long run of blockbuster deals in the drug and biotechnology industries. The deal may be announced as early as Monday, said the people, who asked not to be identified because the matter is still private.



from Biotech News